Results 201 to 210 of about 119,207 (294)

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Journal of Lower Genital Tract Disease, 2013
H. Katki, M. Schiffman, P. Castle, B. Fetterman, Nancy E. Poitras, T. Lorey, L. Cheung, Tina Raine-Bennett, J. Gage, W. Kinney   +9 more
semanticscholar   +1 more source

An Anoikis Resistance Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Blockades in Gastric Cancer

Cancer Innovation, Volume 5, Issue 1, February 2026.
Gastric cancer (GC) has high global incidence and mortality, with most cases diagnosed at advanced stages. Immunotherapy, particularly immune checkpoint blockers (ICBs), has shown promise, but not all patients benefit. This study applied consensus clustering based on anoikis‐related genes (ANRGs) to classify GC into two subclusters.
Xing Cai, Jinru Yang, Fangyuan Zhang, Fuwang Xu, Yuan Fang, Zongbi Yi   +5 more
wiley   +1 more source

Low Preoperative Mean Arterial Pressure as a Risk Factor for Contrast-Induced Nephropathy After Rotational Atherectomy. [PDF]

Rev Cardiovasc Med
Liu X, Wan L, Wu X, Gu Y, Hu L.
europepmc   +1 more source

Passat, pràctica i teoria de l'arqueologia a Turquia [PDF]

, 2006
Duru, Gunes
core  

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Journal of Lower Genital Tract Disease, 2013
H. Katki, M. Schiffman, P. Castle, B. Fetterman, Nancy E. Poitras, T. Lorey, L. Cheung, Tina Raine-Bennett, J. Gage, W. Kinney   +9 more
semanticscholar   +1 more source

Safety and Feasibility of Extended Platelet‐Rich Fibrin as a Solo Barrier Membrane for Ridge Preservation: A Case Series

Clinical and Experimental Dental Research, Volume 12, Issue 1, February 2026.
ABSTRACT Introduction Platelet‐rich fibrin (PRF) has been commonly utilized for ridge preservation techniques either to introduce supraphysiological concentrations of autologous growth factors to the defect area (typically when mixed within a bone graft) or utilized alone as a solo “barrier” membrane.
Nathan E. Estrin, Troy B. Tran, Alan Rene Espinoza, Paras Ahmad, Nima Farshidfar, Ryan Holmes, Yufeng Zhang, Richard J. Miron   +7 more
wiley   +1 more source

ROMO1 as a Diagnostic Biomarker in Cervical Neoplasia: Evidence from Normal, Pre-Invasive, and Invasive Lesions. [PDF]

Diagnostics (Basel)
Tsoneva E, Damyanova P, Metodiev MV, Shivarov V, Vasileva-Slaveva M, Gorcheva Z, Ivanova Y, Kornovski Y, Kostov S, Slavchev S, Nikolova M, Yordanov A, Watrowski R.   +12 more
europepmc   +1 more source

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Journal of Lower Genital Tract Disease, 2013
H. Katki, J. Gage, M. Schiffman, P. Castle, B. Fetterman, Nancy E. Poitras, T. Lorey, L. Cheung, Tina Raine-Bennett, W. Kinney   +9 more
semanticscholar   +1 more source

“Atypical Glandular Cells” on Cervical Cytology: Correlation Between Glandular Cell Component Volume and Histological Follow‐Up

Diagnostic Cytopathology, Volume 54, Issue 2, Page 71-77, February 2026.
ABSTRACT Background Atypical glandular cells (AGC) in cervical cytology, as defined by the Bethesda System, indicate nuclear atypia beyond reactive changes but without definitive features of malignancy. Although clinically significant because it prompts follow‐up procedures, no quantitative threshold exists for AGC diagnosis.
Havva Gokce Terzioglu, Alessa Aragao, Julieta E. Barroeta   +2 more
wiley   +1 more source

Comparative efficacy, feasibility and acceptability of HPV DNA testing on first-void urine versus self-collected vaginal samples: a real-world study in a resource-limited setting. [PDF]

BMJ Glob Health
Bose S, Mandal R, Sengupta S, Dutta S, Abraham P, Muwonge R, Lucas E, Panda CK, Palaniraja S, Rol M, Chakrabarti J, Basu P.   +11 more
europepmc   +1 more source